SA
IONS icon

Sanctuary Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Sanctuary Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$294K Sell
3,918
-584
-13% -$46.1K ﹤0.01% 2114
2025
Q4 		$356K Buy
4,502
+865
+24% +$65.1K ﹤0.01% 1911
2025
Q3 		$238K Buy
+3,637
New +$178K ﹤0.01% 2153
2024
Q4 		– Sell
-9,277
Closed -$316K – 2443
2024
Q3 		$316K Sell
9,277
-7,164
-44% -$333K ﹤0.01% 1956
2024
Q2 		$684K Buy
+16,441
New +$674K 0.01% 1420

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sanctuary Advisors's IONS Position: Q1 2026 in Review

Sanctuary Advisors reduced its Ionis Pharmaceuticals (IONS) stake by 13% in Q1 2026, selling an estimated $46.1K and leaving 3,918 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #2114.

Sanctuary Advisors first reported a position in IONS in Q2 2024 and has held it in 5 quarters since. The position peaked at $684K in Q2 2024. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Sanctuary Advisors held 3,918 shares of Ionis Pharmaceuticals worth $294K as of Q1 2026.
  • Sanctuary Advisors sold 584 Ionis Pharmaceuticals shares in Q1 2026, an estimated $46.1K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Sanctuary Advisors's portfolio in Q1 2026, its #2114 holding.
  • Sanctuary Advisors first reported a position in Ionis Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
  • Sanctuary Advisors's Ionis Pharmaceuticals position peaked at $684K in Q2 2024.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.